Cardiovascular Sciences Inc. (CVSC) is an innovative technology enterprise dedicated to advancing healthcare through the development of specialized medical products. Its diverse portfolio includes cutting-edge solutions designed to address critical cardiovascular and surgical needs. These include: Anti Adhesion Technology, aimed at minimizing post-surgical scarring; its proprietary Pyruvate Therapy, a unique therapeutic method for individuals experiencing cardiac trauma such as ischemic reperfusion injury, heart failure, and complications from bypass surgery; a Thromboresistant Coating that inhibits blood clot formation on medical devices; an advanced, biocompatible Human Vascular Tissue Equivalent for arterial replacement during heart operations; and its patented line of Aortic Catheters.